The Best Oculus Rift S & Quest 2 Prime Day Deals (2021): Top Early Oculus Quest & Rift VR Gaming Headset Sales Highlighted by Save Bubble
Round-up of the latest early Oculus Quest 2 & Rift S VR headset deals for…
Month: June 2021
Tools Prime Day Deals 2021: Best Early Cordless Drill, Tool Box, Table Saw, Power Tools & More Savings Tracked by Saver Trends
Round-up of all the best early tools, saw & drill deals for Prime Day 2021,…
Smart Home Prime Day Deals (2021): Early Home Security, Smart Thermostat, Security Camera & More Deals Found by Consumer Walk
Prime Day 2021 researchers have shared the best early smart home security camera & thermostat…
Craftsman, Milwaukee & DeWalt Prime Day Deals (2021): Top Early Cordless Drill, Miter Saw, Blowers & More Deals Published by Consumer Articles
Amazon Prime Day experts at Consumer Articles have reviewed the top early Milwaukee, DeWalt &…
Prime Day VR Deals 2021: Best Early Oculus, HTC VIVE, PlayStation VR & More VR Headset Savings Compiled by Retail Egg
Summary of all the top early VR headset deals for Prime Day, featuring sales on…
Binamon Revolutionizes the NFT Gaming Experience with Deflationary Tokens
BUENOS AIRES, ARGENTINA / ACCESSWIRE / June 19, 2021 / Launched in 2021, Binamon is…
Recruiting Healthcare Talent and Medical Staff with Heartbeat.ai
NEW YORK, NY / ACCESSWIRE / June 18, 2021 / For human resource (HR) professionals…
Biophytis announces new convertible bond financing for up to €32 million with Atlas and drawing of 2 tranches under the 2020 Atlas Contract for €6 million
PARIS and Cambridge, Mass., June 19, 2021 (GLOBE NEWSWIRE) — Biophytis SA (Nasdaq CM: BPTS,…
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., June 18, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused…
Baudax Bio Announces Special Meeting of Shareholders to Vote on Proposed Increase in Number of Authorized Shares of Common Stock
Special meeting to be held virtually on July 13, 2021, at 9:00 a.m. Eastern Time…
Tarsus Pharmaceuticals, Inc. Schedules Conference Call and Webcast to Announce Saturn-1 Phase 2b/3 Pivotal Trial Results for TP-03 for the Treatment of Demodex Blepharitis
IRVINE, Calif., June 18, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late…
TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at 7th Congress of the European Academy of Neurology
NEW YORK, June 18, 2021 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of…
New Zolgensma data demonstrate age-appropriate development when used presymptomatically and rapid, clinically meaningful efficacy in symptomatic children, even those with severe SMA at baseline
All children (100%) treated presymptomatically in the SPR1NT two-copy cohort survived without respiratory or nutritional…
RAPT Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SOUTH SAN FRANCISCO, Calif., June 18, 2021 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a…
HUTCHMED Announces NMPA Approval of Surufatinib (Sulanda® in China) for Advanced Pancreatic Neuroendocrine Tumors
– Second New Drug Application (“NDA”) approved for Sulanda in China – – The pivotal…
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
Scheduled to Reconvene on June 30, 2021Company Urgently Encourages Stockholders to Vote BUENA, N.J., June…
Evergreen Therapeutics, Inc. Announces Agreement with ICON plc to Conduct Phase II Clinical Trial for COVID-19 Drug Candidate
Bethesda, Maryland , June 18, 2021 (GLOBE NEWSWIRE) — Evergreen Therapeutics, Inc. (“Evergreen,” or the…
Virbac : Declaration of the number of shares and voting rights May 2021
DECLARATION OF THE NUMBER OF SHARES AND VOTING…
European Commission approves Aubagio® (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis
European Commission approves Aubagio® (teriflunomide) as the first oral MS therapy…
Innovation Pharma Announces New Brilacidin Antiviral Research on Non-SARS-CoV-2 Endemic Viral Diseases to be Presented at the 2021 Military Health System Research Symposium
Presentation to be part of the “Development of New Front Line Therapies to Prevent and…